

Contraceptive gel shows promise as alternative to Pill
A birth control gel that is applied to the skin could offer woman an alternative to the Pill, say experts presenting latest trial data. Used once daily, it delivers hormones to ...
Contraceptive Vaginal Gel
Contraceptive Gel. Contraceptive vaginal gel is used either alone or in combination with other contraceptive techniques such as condoms.
Johns Hopkins Gazette: September 30, 1996
On Research: New Contraceptive Gel Prevents Pregnancy and STDs Emil Venere Homewood News and Information: Scientists at Hopkins have created a new type of contraceptive gel for ...
Contraceptive gel as good as the pill
A colourless gel that is rubbed into the skin could become a new contraceptive for women. Scientists have developed a highly advanced gel that will penetrate the skin and ...
Contraceptive gel could replace birth control pill
Rubbing a small amount of the clear gel into the arms, legs, shoulders of abdomen every day delivers a dose of hormones prevents pregnancy, it is claimed. Researchers say it ...
Contraceptive gel could offer alternative to pill
A new contraceptive gel that is applied directly to the skin could offer women an alternative to the pill, a study suggests. The clear gel is put on once a day and ...
Spermicide - Wikipedia, the free encyclopedia
Retrieved 2006-08-13. ^ "Femprotect - Lactic Acid Contraceptive Gel". Woman's Natural Health Practice. Archived from the original on June 1, 2006.
Contraceptive gel could replace the pill
Forgetting to moisturise could soon have serious consequences. Researchers at the American Society for Reproductive Medicine meeting in Colorado this week report that rubbing a ...
Gygel Contraceptive Gel 30g - ExpressChemist.co.uk - Buy Online
Gygel Contraceptive Gel 30g - Buy Online from Express Chemist UK Pharmacy
Contraceptive Gel Side Effects | LIVESTRONG.COM
Contraceptive Gel Side Effects. Contraceptive gels are a method of birth control. These gels contain spermicides and also coat the cervix to prevent the sperm from entering.
New research gains increased respect for contraceptive method
Imagine a contraceptive that could, with one or two painless 15-minute non-surgical treatments, provide months of protection from pregnancy. And imagine that the equipment needed were already in physical therapists' offices around the world.
Ultrasound male contraceptive, overlooked for decades, confirmed to work
( Male Contraception Information Project ) Research released today confirms that therapeutic ultrasound, the same type used by physical therapists, can provide long-acting, non-invasive contraception, when applied to the testes in sessions of as little as 15 minutes.
Sonicating sperm -- the future of male contraception
The ideal male contraceptive would be inexpensive, reliable, and reversible. It would need to be long acting but have few side effects. New research published in BioMed Central's open access journal Reproductive Biology and Endocrinology used commercially available therapeutic ultrasound equipment to reduce sperm counts of male rats to levels which would result in infertility in humans.
Watson's Drug Fails to Get Support
Watson Pharmaceuticals Inc. and Columbia Laboratories Inc. recently announced that the US Food and Drug Administration's advisory committee recommended against the approval of progesterone vaginal gel....
BioSante Pharmaceuticals Provides Corporate Update
BioSante Pharmaceuticals, Inc. today announced a corporate update.
Transdermal Drug Delivery - Technologies, Markets, and Companies
NEW YORK, Feb. 1, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Transdermal Drug Delivery - Technologies, Markets, and Companies http://www.reportlinker.com/p0203552/Transdermal-Drug-Delivery---Technologies-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_TechnologyThis ...
Watson's Drug Fails to Get Support - Analyst Blog
Watson Pharmaceuticals Inc. ( WPI ) and Columbia Laboratories Inc. ( CBRX ) recently announced that the US Food and Drug Administration's (FDA) advisory committee recommended
Watson Announces Preliminary 2011 Non-GAAP Earnings of $4.75-$4.77
PARSIPPANY, N.J., Jan. 24, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI - News) today announced preliminary 2011 non-GAAP earnings per share of $4.75-$4.77, a 39 percent increase over 2010 full ...
Lubiprostone Meets Primary Endpoint in Phase 3 Clinical Trial for Opioid-Induced Bowel Dysfunction (OBD)
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc. announced today that lubiprostone met the primary endpoint in a phase 3 clinical trial fo
Africa: Empowering Women to Fight HIV
[allAfrica.com] What makes a young African doctor decide to devote her career to helping women fight HIV? Dr. Sengeziwe Sibeko is a 37-year-old medical researcher with a degree in obstetrics and gynecology from the University of KwaZulu Natal (UKZN) in South Africa, an MSc in epidemiology from Columbia University in the United States, and is about to take up a fellowship to study for her PhD at ...